📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Targeting of Aberrant avß6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells (2017)

First Author: Whilding L

Attributed to: King's Health Partners Confidence in Concept funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ymthe.2017.09.018

PubMed Identifier: 28958577

Publication URI: http://europepmc.org/abstract/MED/28958577

Type: Journal Article/Review

Parent Publication: Molecular Therapy

Issue: 10

ISSN: 1525-0016